Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Biomarkers / ADH5



This biomarker is also known as:
  • EC,EC 1.1.1.-,EC,
  • GSNOR,
  • ADH-3,
  • GSH-FDH,
  • ADHX,
  • formaldehyde dehydrogenase,
  • S-(hydroxymethyl)glutathione dehydrogenase,
  • Alcohol dehydrogenase class-III,
  • alcohol dehydrogenase (class III), chi polypeptide,
  • alcohol dehydrogenase class-3,
  • alcohol dehydrogenase class-III,
  • Alcohol dehydrogenase class chi chain,
  • FALDH,
  • Alcohol dehydrogenase 5,
  • glutathione-dependent formaldehyde dehydrogenase,
  • alcohol dehydrogenase 5 (class III), chi polypeptide,
  • Glutathione-dependent formaldehyde dehydrogenase,
  • FDH,
  • alcohol dehydrogenase class chi chain,

View in BioMuta


ADH5 is a member of the alcohol dehydrogenase family. This protein forms a homodimer. ADH5 is ineffective in oxidizing ethanol, but exhibits high activity for oxidation of long-chain primary alcohols and for oxidation of S-hydroxymethyl-glutathione, a spontaneous adduct between formaldehyde and glutathione. There are several non-transcribed pseuodogenes related to this gene.


QA State: Curated
Type: Protein
Short Name:


There are no datasets associated with this biomarker.


The following organs have data associated with this biomarker…



Phase: Two
QA State: Under Review


No additional breast data available.

Performance Comment

ADH5 was one of numerous potential early detection biomarkers specific to triple-negative breast cancer in multiple pathways identified.


This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at if you should have access to this biomarker.


The final report of the 2013 Cancer Biomarkers Bioinformatics Workshop is now available.

Announcement 03/06/2014

Thank you to everyone who helped make the 27th EDRN Steering Committee Meeting a success. We look forward to seeing everyone at the 9th EDRN Scientific Workshop from September 8-11, 2014 in Washington D.C.